FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
Titel:
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
Auteur:
Verger, Antoine Yakushev, Igor Albert, Nathalie L. van Berckel, Bart Brendel, Matthias Cecchin, Diego Fernandez, Pablo Aguiar Fraioli, Francesco Guedj, Eric Morbelli, Silvia Tolboom, Nelleke Traub-Weidinger, Tatjana Van Weehaeghe, Donatienne Barthel, Henryk
Verschenen in:
European journal of nuclear medicine and molecular imaging